Joon Lee
Stock Analyst at Truist Financial
(4.97)
# 85
Out of 5,023 analysts
517
Total ratings
59.5%
Success rate
37.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Joon Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EDIT Editas Medicine | Reiterated: Hold | n/a | $2.62 | - | 22 | Mar 17, 2026 | |
| VYGR Voyager Therapeutics | Reiterated: Buy | n/a | $2.45 | - | 16 | Mar 17, 2026 | |
| SLDB Solid Biosciences | Reiterated: Buy | n/a | $6.85 | - | 11 | Mar 13, 2026 | |
| PRAX Praxis Precision Medicines | Reiterated: Buy | $700 | $295.51 | +136.88% | 29 | Mar 12, 2026 | |
| VRTX Vertex Pharmaceuticals | Reiterated: Buy | $525 | $504.73 | +4.02% | 16 | Mar 11, 2026 | |
| ANAB AnaptysBio | Reiterated: Hold | $50 | $48.53 | +3.03% | 30 | Mar 9, 2026 | |
| VKTX Viking Therapeutics | Reiterated: Buy | n/a | $29.94 | - | 43 | Mar 5, 2026 | |
| BMRN BioMarin Pharmaceutical | Reiterated: Buy | n/a | $57.18 | - | 14 | Mar 3, 2026 | |
| CORT Corcept Therapeutics | Reiterated: Buy | n/a | $116.23 | - | 38 | Mar 2, 2026 | |
| CRSP CRISPR Therapeutics AG | Reiterated: Buy | n/a | $55.43 | - | 24 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $12.26 | - | 29 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $63.46 | - | 11 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.78 | - | 41 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $41.75 | - | 3 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $235.67 | - | 26 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $179.25 | - | 37 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 → $76 | $15.22 | +399.34% | 29 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $32.17 | - | 2 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.96 | - | 8 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.63 | - | 24 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $919.21 | n/a | 38 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $11.36 | n/a | 1 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $7.19 | n/a | 10 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $65 | $7.41 | n/a | 5 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $4 | $3.60 | n/a | 4 | Dec 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $15.51 | n/a | 1 | Aug 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $5.03 | n/a | 1 | Jun 19, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $76 | $23.46 | n/a | 1 | Jun 19, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $17.50 | n/a | 1 | Aug 8, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $19.95 | n/a | 1 | Aug 7, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $1.13 | n/a | 1 | Jul 28, 2014 |
Editas Medicine
Mar 17, 2026
Reiterated: Hold
Price Target: n/a
Current: $2.62
Upside: -
Voyager Therapeutics
Mar 17, 2026
Reiterated: Buy
Price Target: n/a
Current: $2.45
Upside: -
Solid Biosciences
Mar 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $6.85
Upside: -
Praxis Precision Medicines
Mar 12, 2026
Reiterated: Buy
Price Target: $700
Current: $295.51
Upside: +136.88%
Vertex Pharmaceuticals
Mar 11, 2026
Reiterated: Buy
Price Target: $525
Current: $504.73
Upside: +4.02%
AnaptysBio
Mar 9, 2026
Reiterated: Hold
Price Target: $50
Current: $48.53
Upside: +3.03%
Viking Therapeutics
Mar 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $29.94
Upside: -
BioMarin Pharmaceutical
Mar 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $57.18
Upside: -
Corcept Therapeutics
Mar 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $116.23
Upside: -
CRISPR Therapeutics AG
Mar 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $55.43
Upside: -
Mar 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $12.26
Upside: -
Feb 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $63.46
Upside: -
Feb 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $3.78
Upside: -
Feb 26, 2026
Reiterated: Buy
Price Target: n/a
Current: $41.75
Upside: -
Feb 25, 2026
Reiterated: Buy
Price Target: n/a
Current: $235.67
Upside: -
Feb 24, 2026
Reiterated: Buy
Price Target: n/a
Current: $179.25
Upside: -
Feb 13, 2026
Reiterated: Buy
Price Target: $90 → $76
Current: $15.22
Upside: +399.34%
Nov 10, 2025
Reiterated: Buy
Price Target: n/a
Current: $32.17
Upside: -
Nov 6, 2025
Reiterated: Buy
Price Target: n/a
Current: $2.96
Upside: -
Nov 5, 2025
Reiterated: Buy
Price Target: n/a
Current: $4.63
Upside: -
Aug 1, 2025
Reiterated: Buy
Price Target: n/a
Current: $919.21
Upside: n/a
Dec 4, 2024
Rated: Buy
Price Target: n/a
Current: $11.36
Upside: n/a
Nov 14, 2023
Reiterated: Buy
Price Target: $18
Current: $7.19
Upside: n/a
Jan 17, 2023
Reiterated: Buy
Price Target: $100 → $65
Current: $7.41
Upside: n/a
Dec 8, 2022
Reiterated: Hold
Price Target: $7 → $4
Current: $3.60
Upside: n/a
Aug 8, 2019
Reiterated: Buy
Price Target: $10
Current: $15.51
Upside: n/a
Jun 19, 2019
Initiated Coverage: Buy
Price Target: $20
Current: $5.03
Upside: n/a
Jun 19, 2019
Initiated Coverage: Buy
Price Target: $76
Current: $23.46
Upside: n/a
Aug 8, 2014
Reiterated: Buy
Price Target: n/a
Current: $17.50
Upside: n/a
Aug 7, 2014
Reiterated: Buy
Price Target: $33
Current: $19.95
Upside: n/a
Jul 28, 2014
Reiterated: Buy
Price Target: $14
Current: $1.13
Upside: n/a